Rho Federal Systems Division, Inc. NIAID DAIT SACCC
Rho Federal Systems Division, Inc. NIAID DAIT SACCC
批准号:
10823519
负责人:
Gloria David
金额:
$280.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-07 至 2023-04-30
关键词:
Allergic DiseaseApplied ResearchAreaAsthmaAutoimmuneAutoimmune DiseasesAwardBasic ScienceBiological Specimen BanksClinicalClinical InvestigatorClinical ResearchClinical Trials Data Monitoring CommitteesCollaborationsCollectionCommunicable DiseasesCommunicationContractsDataData AnalysesData CollectionData ReportingDedicationsDevelopmentDiseaseEnsureEthicsEventHealthHuman ResourcesHypersensitivityImmune System DiseasesImmunologyIndividualInfrastructureLaboratoriesManagement Information SystemsMissionMonitorNational Institute of Allergy and Infectious DiseaseOrgan Transplant ResearchPatientsPreparationProceduresProcessProtocols documentationPublicationsRandomizedRecommendationReportingResearchResearch PersonnelResearch SupportResourcesSafetyScientistSecureSerious Adverse EventServicesSolidStandardizationStatistical Data InterpretationStructureStudy SubjectSystemTechnologyTestingTransplantationWorkWritingclinical research siteclinical trainingdata managementdesignexperiencehigh dimensionalityimprovedinstrumentmeetingsmemberpatient safetyperformance sitepreventprogramsprotocol developmentresearch studyrhosample collectionstatisticssuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project is a one-year extension of the consolidated DAIT Statistical and Clinical Coordinating Center
(DAIT SACCC). The extension will enable crucial continuity of services while the individual successor
contracts assuming the work of the DAIT SACCC are awarded and any necessary transitions occur. The
DAIT SACCC supports research in the areas of asthma and allergic diseases, autoimmune diseases, and
transplantation. The objective of the DAIT SACCC is to provide efficient coordination of the following
services: protocol development, study initiation and management, statistical design and analysis, clinical
site monitoring, ancillary services, data management, and safety oversight. During the extension, the DAIT
SACCC will continue to (1) provide staff experienced in research conducted by DAIT-supported consortia
and organize these staff in an administrative structure that manages resources efficiently, is responsive to
the needs of the research consortia and DAIT, and facilitates communication and collaboration; (2) provide
experienced scientists and statisticians who, in collaboration with clinical investigators and DAIT officials,
design and analyze studies across the full scope of research; (3) facilitate the development, review, and
revision of protocols and protocol-related documents through dedicated protocol teams; (4) provide study
initiation and study management functions required for the efficient, valid, and ethical conduct of studies;
(5) provide well-developed procedures and personnel for the monitoring of clinical sites; (6) provide efficient
and accurate tracking and reconciliation of specimen collection and distribution; (7) provide integrated and
secure information management systems and procedures for the collection of clinical and mechanistic data;
(8) help ensure patient safety by providing high-quality serious adverse event (SAE) reporting and Data
and Safety Monitoring Board (DSMB) reports; and (9) provide tools, infrastructure, and analytical support in
the planning, implementation, analysis, and dissemination of high dimensional mechanistic studies.
期刊论文(74)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/bjd.13350
发表时间:
2015-03
期刊:
The British journal of dermatology
影响因子:
--
作者:
[Hall RP 3rd, Fairley J, Woodley D, Werth VP, Hannah D, Streilein RD, McKillip J, Okawa J, Rose M, Keyes-Elstein LL, Pinckney A, Overington A, Wedgwood J, Ding L, Welch B]
通讯作者:
Welch B
Pathways through which asthma risk factors contribute to asthma severity in inner-city children.
哮喘危险因素导致内城区儿童哮喘严重程度的途径。
DOI:
10.1016/j.jaci.2016.06.060
发表时间:
2016-10
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
[Liu AH, Babineau DC, Krouse RZ, Zoratti EM, Pongracic JA, O'Connor GT, Wood RA, Khurana Hershey GK, Kercsmar CM, Gruchalla RS, Kattan M, Teach SJ, Makhija M, Pillai D, Lamm CI, Gern JE, Sigelman SM, Gergen PJ, Togias A, Visness CM, Busse WW]
通讯作者:
Busse WW
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.
自体干细胞移植或环磷酰胺治疗硬皮病后的临床和分子发现:处理缺失的纵向数据。
DOI:
10.1002/acr.24785
发表时间:
2023
期刊:
Arthritis care & research
影响因子:
4.7
作者:
[Keyes-Elstein,Lynette, Pinckney,Ashley, Goldmuntz,Ellen, Welch,Beverly, Franks,JenniferM, Martyanov,Viktor, Wood,TammaraA, Crofford,Leslie, Mayes,Maureen, McSweeney,Peter, Nash,Richard, Georges,George, Csuka,ME, Simms,Robert, Furst,Danie]
通讯作者:
Furst,Danie
Impact of Past Research Experience on Subsequent Trials: A Caution.
过去的研究经验对后续试验的影响:警告。
DOI:
10.1164/rccm.201905-0926le
发表时间:
2020
期刊:
American journal of respiratory and critical care medicine
影响因子:
24.7
作者:
[Villarreal,MiguelA, Wildfire,JeremyJ, Sorkness,ChristineA, Gergen,PeterJ, Visness,CynthiaM, Mitchell,HermanE]
通讯作者:
Mitchell,HermanE
DOI:
10.1001/archneurol.2010.222
发表时间:
2010-09
期刊:
ARCHIVES OF NEUROLOGY
影响因子:
--
作者:
[Khoury, Samia J., Healy, Brian C., Kivisakk, Pia, Viglietta, Vissia, Egorova, Svetlana, Guttmann, Charles R. G., Wedgwood, Josiah F., Hafler, David A., Weiner, Howard L., Buckle, Guy, Cook, Sandra, Reddy, Susheel]
通讯作者:
Reddy, Susheel
共 42 条
RhoFED AA-SCCC
-
批准号:10746035
-
项目类别:
-
资助金额:$919.2万
-
财政年份:2023
-
负责人:Gloria David
-
依托单位:
Rho Federal Systems Division, Inc. NIAID DAIT SACCC
-
批准号:10364588
-
项目类别:
-
资助金额:$1584.38万
-
财政年份:2021
-
负责人:Gloria David
-
依托单位:
Leadership Group
-
批准号:10823525
-
项目类别:
-
资助金额:$280.0万
-
财政年份:2015
-
负责人:Gloria David
-
依托单位:
Core-004
-
批准号:10594712
-
项目类别:
-
资助金额:$167.77万
-
财政年份:2015
-
负责人:Gloria David
-
依托单位:
Leadership Group
-
批准号:10594715
-
项目类别:
-
资助金额:$162.66万
-
财政年份:2015
-
负责人:Gloria David
-
依托单位:
Rho Federal Systems Division, Inc. NIAID DAIT SACCC
-
批准号:10589242
-
项目类别:
-
资助金额:$1676.28万
-
财政年份:2015
-
负责人:Gloria David
-
依托单位:
Core-003
-
批准号:10594711
-
项目类别:
-
资助金额:$509.12万
-
财政年份:2015
-
负责人:Gloria David
-
依托单位:
Project-002
-
批准号:10594708
-
项目类别:
-
资助金额:$181.34万
-
财政年份:2015
-
负责人:Gloria David
-
依托单位:
Core-002
-
批准号:10594710
-
项目类别:
-
资助金额:$461.0万
-
财政年份:2015
-
负责人:Gloria David
-
依托单位:
Core-001
-
批准号:10594709
-
项目类别:
-
资助金额:$194.38万
-
财政年份:2015
-
负责人:Gloria David
-
依托单位:
Leadership Group
-
批准号:10599486
-
项目类别:
-
资助金额:$300.0万
-
财政年份:2015
-
负责人:Gloria David
-
依托单位:
海外基金